Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
cancer
4
×
life sciences
national blog main
national top stories
san francisco blog main
4
×
boston top stories
national
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ipo
medical device
new york top stories
orbimed
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
actavalon
acute myeloid leukemia
aileron therapeutics
aprea therapeutics
arimoclomol
armo biosciences
arnold levine
What
public
4
×
ipo
company
drugs
files
firms
life
science
advance
answer
away
biology
biotechs
blood
broader
cancer
club
companies
continued
crop
cytokine
democratic
dems
detect
developing
discontent
election
enhanced
exceeded
grail
group
haul
high
house
initial
intended
investors
join
joined
latest
Language
unset
Current search:
cancer
×
public
×
" san francisco blog main "
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M